AZ-10397767

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAZ-10397767
Drug Alias Namethiazolopyrimidine-based CXCR2/CCR2b dual antagonists (AstraZeneca)AZ-10397767
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonistsC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2C-X-C motif chemokine receptor 2
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A